Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in DRTS — Alpha Tau Medical Ltd.

CIK 1446194 BALA CYNWYD, PA
Back to DRTS Full portfolio

Position in DRTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$688,968
+$457,511 QoQ
Shares Held
54,767
+18.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 74 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DRTS Over Time

Shares Held

Position Value (USD)

Derivatives in DRTS

reported options exposure · as of Jun 30, 2026
CallValue
$4,547,670
CallShares
361,500
PutValue
$327,080
PutShares
26,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. DRTS ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in DRTS

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $688,968 54,767
2026-06-30 $4,547,670 361,500
2026-06-30 $327,080 26,000
2026-03-31 $358,449 50,700
2026-03-31 $231,457 32,738